Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Total Liabilities (2023 - 2025)

Rallybio (RLYB) has disclosed Total Liabilities for 3 consecutive years, with $4.3 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities fell 33.3% to $4.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Dec 2025, down 33.3% year-over-year, with the annual reading at $4.3 million for FY2025, 33.3% down from the prior year.
  • Total Liabilities hit $4.3 million in Q4 2025 for Rallybio, down from $4.6 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $12.4 million in Q2 2024 to a low of $3.9 million in Q1 2025.
  • Historically, Total Liabilities has averaged $7.5 million across 3 years, with a median of $7.7 million in 2023.
  • Biggest five-year swings in Total Liabilities: skyrocketed 49.22% in 2024 and later tumbled 61.67% in 2025.
  • Year by year, Total Liabilities stood at $9.4 million in 2023, then plummeted by 31.6% to $6.5 million in 2024, then tumbled by 33.3% to $4.3 million in 2025.
  • Business Quant data shows Total Liabilities for RLYB at $4.3 million in Q4 2025, $4.6 million in Q3 2025, and $5.0 million in Q2 2025.